IP Verse

Bifidobacterium Longum And Functional Gi Disorders - EP2289527

The patent EP2289527 was granted to Nestec on Feb 21, 2018. The application was originally filed on Aug 25, 2009 under application number EP09168590A. The patent is currently recorded with a legal status of "Revoked".

EP2289527

NESTEC
Application Number
EP09168590A
Filing Date
Aug 25, 2009
Status
Revoked
Oct 6, 2023
Grant Date
Feb 21, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MORINAGA MILK INDUSTRYNov 21, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONEP1384483
EXAMINATIONWO03010297
EXAMINATIONWO2006041930
OPPOSITIONEP2110028
OPPOSITIONEP2470188
OPPOSITIONEP3072398
OPPOSITIONWO2007093619
OPPOSITIONWO2011023689
SEARCHEP1974735
SEARCHEP2110028
SEARCHWO2004112507
SEARCHWO2007093619

Non-Patent Literature (NPL) Citations (52) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Ii Riconoscere ET AL, "APPROACH TO THE PATIENT WITH DISORDERS OF INTESTINAL FUNCTION Anemgi Welcome Programme Scientific Information Author Index", (20060301), URL: http://messaggi-publisher.org/Journals/NeUroGastro2006/NUG1_2006.pdf, (20160122), XP055243887-
OPPOSITION- ABE, Food Style, (20020000), vol. 6, no. 9-
OPPOSITION- BENNETT, "Level of chronic life stress predicts clinical outcome in irritable bowel syndrome", Gut, (19980000), vol. 43, pages 256 - 61, XP055535967-
OPPOSITION- BROWN, "T1301 Bifidobacterium Longum BB-536 and Prevention of Acute Pouchitis", AGA Abstract, page A-465-
OPPOSITION- COLECCHIA, "Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study", Minerva Gastroenterologica E Dietologica, vol. 52, no. 4, pages 349 - 358 2006, XP008177017-
OPPOSITION- CREED, "Psychological treatments of the irritable bowel syndrome: a review", Gut, (19890000), vol. 30, pages 1601 - 1609, XP055535961-
OPPOSITION- DROSSMAN, "The functional gastrointestinal disorders and the Rome II process", Gut, (19990000), vol. 45, no. II, pages II1 - II5, XP055536022-
OPPOSITION- EBISAWA, "Experience in Dosing Obstetrical and Gynecological Inpatients with Bifidobacterium-Containing Yoghurt 'La Sante'", Clinical Nutrition ( Japan ), (19850000), vol. 66, no. 7, pages 805 - 810, XP055535686-
OPPOSITION- Extract from EUIPO register for the trademark 2018 ''BB536-
OPPOSITION- Extract from Oxford Dictionary re definitions of anxiety and stress, (19980000), ISBN 0-19-861263-X-
OPPOSITION- FANIGLIULO, "Role of gut microflora and probiotic effects in the irritable bowel syndrome", Acta Biomed, (20060000), vol. 77, pages 85 - 89, XP009193592-
OPPOSITION- FUKUSHIMA, The annual report of the Kyoritu College, (19910000), vol. 36, pages 1 - 11-
OPPOSITION- HOLOWACZ, "M1146 A randomized controlled trial of the probiotic combination LactibianeR in irritable bowel syndrome, the LactibianeR study group", Gastroenterology, Digestive Disease Week and the 108th Annual Meeting of the AGA Institute, (20070000), XP055535921-
OPPOSITION- "Inflammatory Bowel Disease and Irritable Bowel Syndrome Similarities and Differences", Crohn's and Colitis Foundation of America, (20140000), pages 1 - 11, XP055536047-
OPPOSITION- MAYER, "The neurobiology of stress and gastrointestinal disease", Gut, (20000000), vol. 47, pages 861 - 869, XP055535946-
OPPOSITION- NODDIN, "Irritable Bowel Syndrome and Functional Dyspepsia: Different Diseases or a Single Disorder With Different Manifestations", MeGenMed, vol. 7, no. 3, (20050000), pages 1 - 18, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1681633/?report=printable, XP055535878-
OPPOSITION- OGATA, "Effect of Bifidobacterium longum 88536 Administration on the Intestinal Environment, Defecation Frequency and Fecal Characteristics of Human Volunteers", Bioscience Microflora, (19970000), vol. 16, no. 2, pages 53 - 58, XP055535692-
OPPOSITION- O'MAHONY, "Is Bifidobacterium a more effective probiotic therapy than Lactobacillus for patients with irritable bowel syndrome?", Nature Clinical Practice, (20050000), vol. 2, no. 7, pages 304 - 305, XP055535862-
OPPOSITION- RISTIC, "EFEKAT FUNKCIONALNOG MLECNOG PROIZVODA OBOGACENOG KULTUROM Bifidobacterium /ongum 88536 U TRETMANU GOJAZNOSTI/THE EFFECTS OF FUNCTIONAL DAIRY PRODUCTS ENRICHED WITH THE CULTURE, Bifidobacterium longum BB536 I IN THE TREATMENT OF OBESITY", Prehrambena industrija, (20020000), vol. 1-2, pages 81 - 84, XP055535678-
OPPOSITION- SEKI, "The Effect of Bifidobacterium Cultured Milk on the “Regularity” among on Aged Group", Journal of Japanese Society Nutrition and Food, (19780000), vol. 31, no. 4, pages 379 - 387, XP055535705-
OPPOSITION- TOMODA, "Effect of Administration of Yogurt Containing Bifidobacteriumin Healthy Persons", Bifidus (Japan), (19900000), vol. 4, no. 1, pages 21 - 24, XP055535681-
OPPOSITION- XIAO, "Effect of yogurt containing Bifidobacterium longum 88536 on the defecation frequency and fecal characteristics of healthy adults : A double-blind crossover study.", Japanese Journal of Lactic Acid Bacteria, (20070000), vol. 18, no. 1, pages 31 - 36, XP055535532-
OPPOSITION- YAESHIMA, "Effect of non-fermented milk containing Bifidobacterium longum BB 536 on the defecation frequency and fecal characteristics in healthy adults", Journal of Nutrition Food, (20010106), vol. 4, no. 2, pages 1 - 6, XP055535680-
OPPOSITION- YAESHIMA, "Effect of Sweet Yogurt Containing Bifidobacterium longum BB536 on Defecation Frequency and Fecal Characteristics of Healthy Adults: A Comparison with Sweet Standard Yogurt", Journal of Nutrition Food, (19980106), vol. 1, no. 3/4, pages 1 - 6, XP055535538-
OPPOSITION- HAYS, "A Systematic Review of the Role of Hydrolyzed Infant Formulas in Allergy Prevention", Arch Pediatr Adolesc Med, (20050000), vol. 159, pages 810 - 816, XP055535934
OPPOSITION- TAKEDA, "Upregulation of T-bet and Tight Junction Molecules by Bifidobactrium longum Improves Colonic Inflammation of Ulcerative Colitis", Inflamm Bowel Dis, (20090100), vol. 15, pages 1617 - 1618, XP055536142
OPPOSITION- NARDUCCI, "Increased colonic motility during exposure to a stressful situation", Digestive Diseases and Sciences, (19850000), vol. 30, no. 1, pages 40 - 44, XP055536127
OPPOSITION- GRUENWALD, "Effect of a Probiotic Multivitamin Compound on Stress and Exhaustion", Advances in Therapy, (20020000), vol. 19, no. 3, pages 141 - 150, XP055535693
OPPOSITION- LOGAN, "Major depressive disorder: probiotics may be an adjuvant therapy", Medical Hyptheses, (20050000), vol. 64, pages 533 - 538, XP004691105
OPPOSITION- DIOP, "Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial", Nutrition Research, (20080101), vol. 28, no. 1, pages 1 - 5, XP022420472
OPPOSITION- MERTZ, "Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention", Gastroenterology, (20000000), vol. 118, pages 842 - 848, XP005138571
OPPOSITION- KIM, "W1389 Probiotics in clinical trials from 2004 to 2007: A review of current literature", Gastroenterology, Digestive Disease Week and the 108th Annual Meeting of the AGA Institute May 17-22, 2008 Dan Diego, CA, (20080400), page A-694, XP055535927
OPPOSITION- KANAZAWA, "Patients and Nonconsulters with Irritable Bowel Syndrome Reporting a Parental History of Bowel Problems Have More Impaired Psychological Distress", Digestive Diseases and Sciences, (20040000), vol. 49, no. 6, pages 1046 - 1053, XP019237079
OPPOSITION- BALLONGUE, "Action sur la flore intestinale de laits fermentes au Bifidobacterium", Lait, vol. 73, ( ), pages 249 - 256, XP055535845
OPPOSITION- O'MAHONY, "Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles", Gastroenterology, (20050000), vol. 128, pages 541 - 551, XP002479504
OPPOSITION- "Functional Bowel Disorders", Longstreth, Gastroenterology, (20060000), vol. 130, pages 1480 - 1491, XP005442445
OPPOSITION- ROTH, "Mindfulness-Based Stress Reduction and Health-Related Quality of Life: Findings From a Bilingual Inner-City Patient Population", Psychosom Med, (20040000), vol. 66, pages 113 - 123, XP055535943
OPPOSITION- ZENG, "Clinical trial : effect of active lactic acid bacteria on mucosaI barrier function in patients with diarrhoea-predominant irritable bowel syndrome", Alimentary Pharmacology & Therapeutics, (20081028), vol. 28, pages 994 - 1002, XP055535930
OPPOSITION- ABE, "Stability of bifidobacteria in powdered formula", International Journal of Food Science, (20090000), vol. 44, pages 718 - 724, XP055535855
OPPOSITION- KABEIR, "Growth of Bifidobacterium longum 88536 in medida (fermented cereal porridge) and their survival during refrigerated storage", Letters in Applied Microbiology, (20050000), vol. 41, pages 125 - 131, XP055536005
OPPOSITION- GUYONNET, "Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study", Journal of Digestive Diseases, (20090200), vol. 10, pages 61 - 70, XP002579815
OPPOSITION- SUDO, "Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice", Journal of Physiology, (20040000), vol. 558, no. 1, pages 263 - 275, XP055352332
OPPOSITION- THOMPSON, "Functional bowel disorders and functional abdominal pain", Gut, (19990000), vol. 45, no. II, pages II43 - II47, XP055536030
OPPOSITION- MERTZ, "Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans", Gut, (20020000), vol. 51, no. l, pages i29 - i33, XP055535948
OPPOSITION- MONNIKES, "Role of Stress in Functional Gastrointestinal Disorders", Dig Dis, (20010000), vol. 19, pages 201 - 211, XP055536091
OPPOSITION- WANG, "The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria", BMC Gastroenterology, (20080900), pages 1 - 7, XP021042696
OPPOSITION- LEIBBRAND, "Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire", International Journal of Behavioral Medicine, (20020000), vol. 9, no. 2, pages 155 - 172, XP055535696
OPPOSITION- ARAYA-KOJIMA, "Inhibitory Effects of Bifidobacterium longum BB536 on Harmful Intestinal Bacteria", Bifidobacteria Microflora, (19950000), vol. 14, no. 2, pages 59 - 66, XP055535867
OPPOSITION- VILJOEN, SA, "Die effek van probiotika op die simptome en immunoglobulienvlakke van prikkelbare dermsindroom", SA Tydskrif vir Natuurwetenskap en Tegnologie, (20040000), vol. 23, no. 1/2, pages 22 - 24, XP055535914
OPPOSITION- CREED, "Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome", Annals of Internal Medicine, (20010000), vol. 134, no. 9, pages 860 - 866, XP055536137
OPPOSITION- ABE, "Effects of storage temperature and water activity on thesurvival of bifidobacteria in powder form", International Journal of Dairy Technology, (20090500), vol. 62, no. 2, pages 234 - 239, XP055536012
SEARCH- PUCCIO ET AL, "Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics", NUTRITION, ELSEVIER INC, US, (20061222), vol. 23, no. 1, ISSN 0899-9007, pages 1 - 8, XP005812913 [X] 1,2,4,6,7,10 * abstract * * page 6, column 1, line 10 - line 11; figure 4 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents